This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Report Scope
- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - The analyst’s summarization of the company’s business strategy.
- SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.
Highlights
Exact Sciences Corp (Exact Sciences), a subsidiary of Abbott Laboratories, is a molecular diagnostic company that focuses on the development of tests for various types of cancers. The company develops and delivers solutions for cancer detection and treatment guidance. Its major products include the Cologuard test, Oncotype DX tests, and a non-invasive colorectal cancer screening test, which provide genomic insights for cancer treatment. The company operates through a network of healthcare providers and partners to distribute its products. Exact Sciences is headquartered in Madison, Wisconsin, the US.Exact Sciences Corp Key Recent Developments
- Mar 13, 2026: Workflow Services Supports Walgreens' National Colorectal Cancer Initiative Using Cologuard Tests
- Mar 04, 2026: Exact Sciences Named Gallup Exceptional Workplace Award Winner for Third Consecutive Year
- Mar 03, 2026: Privia Health Program Achieves 84% Colorectal Cancer Screening Rate Through Industry Collaboration
- Feb 13, 2026: Exact Sciences Announces Record Fourth Quarter and Full Year 2025 Results
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with the analyst’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Quest Diagnostics Inc
- Natera Inc
- Labcorp Holdings Inc
- Geneoscopy LLC
- Freenome Inc
- Color Health Inc
- Variantyx Inc
- Siemens AG
- Roche Holding AG
- Myriad Genetics Inc
- Illumina Inc
- Grail Inc
- Agendia Inc
- Veracyte Inc
- Guardant Health Inc
- GeneDX LLC
- Hologic Inc

